People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Hospitals and Physicians, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oncology Institute, Inc. | — | Hospitals and Physicians | Series D+ | $126.4M | $144.8M | 2022 |
| Cecelia Health Holdings, Inc. | — | Healthtech | Series B | $37.7M | $79.7M | 2025 |
Richard Barasch at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Barasch on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew Miller | 1 | 15 |
| Mihir Shah | 1 | 7 |
| Cody Nystrom | 1 | 5 |
| Mark Pacala | 1 | 5 |
| Mohit Kaushal | 1 | 4 |
| Ravi Sarin | 1 | 3 |
| Eric Edidin | 1 | 3 |
| Charles Flicker | 1 | 2 |
| Gabriel Ling | 1 | 2 |
| Robert Carter | 1 | 2 |
| Cody G. Nystrom | 1 | 2 |
| Saul Richter | 1 | 2 |
| David G. Weingard | 1 | 2 |
| Jeffrey G. Becker | 1 | 2 |
| Orrin G. Feingold | 1 | 2 |
| Brad G. Wilson | 1 | 2 |
| Maeve O'Meara | 1 | 1 |
| David Lombardi | 1 | 1 |
| Mark Clermont | 1 | 1 |
| Matthew Klinger | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.